Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013)
Bio-Rad Laboratories (BIO) posted quarterly Income from Non-Controlling Interests of $21000.0 for Q1 2013, up 134.43% year-over-year from $8958.0 in Q1 2012, and up 126.58% quarter-over-quarter from -$79000.0 in Q4 2012.
Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Income from Non-Controlling Interests for 5 consecutive years, with $21000.0 the latest figure, recorded in Q1 2013.
- In Q1 2013, Income from Non-Controlling Interests rose 134.43% year-over-year to $21000.0; the TTM figure through Dec 2013 stood at $21000.0 (down 69.57% YoY), while the FY2013 annual figure was $21000.0, down 69.57% from the prior year.
- Income from Non-Controlling Interests climbed to $21000.0 in Q1 2013 per BIO's latest filing, from -$79000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $776000.0 in Q3 2009 and bottomed at -$1.3 million in Q2 2009.
- Historically, Income from Non-Controlling Interests has averaged $90000.0 across 5 years, with a median of $4000.0 in 2012.
- Annual changes were most pronounced in 2011 — Income from Non-Controlling Interests tumbled 231.03% — and 2012, when it surged 953.85%.
- Bio-Rad Laboratories' Income from Non-Controlling Interests stood at $660000.0 in 2009, then slumped by 95.61% to $29000.0 in 2010, then sank by 231.03% to -$38000.0 in 2011, then sank by 107.89% to -$79000.0 in 2012, then surged by 126.58% to $21000.0 in 2013.
- Business Quant data shows BIO's Income from Non-Controlling Interests at $21000.0 in Q1 2013, -$79000.0 in Q4 2012, and -$13000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Bio-Rad Laboratories | 10.07 Bn | 8.45 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 21,000.00 |
| Dec 31, 2012 | -79,000.00 |
| Sep 30, 2012 | -13,000.00 |
| Jun 30, 2012 | 222,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Sep 30, 2011 | -35,000.00 |
| Jun 30, 2011 | -26,000.00 |
| Mar 31, 2011 | -101,000.00 |
| Dec 31, 2010 | 29,000.00 |
| Sep 30, 2010 | 321,000.00 |
| Jun 30, 2010 | 564,000.00 |
| Mar 31, 2010 | 531,000.00 |
| Dec 31, 2009 | 660,000.00 |
| Sep 30, 2009 | 776,000.00 |
| Jun 30, 2009 | -1.33 Mn |